EAACI Congress 2024
BackAllergen immunotherapy 3
Saturday 01 Jun, 12:00 PM -
13:00 PM Valencia, Spain
Poster Zone
Thematic Poster Session
12:00
Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants
12:00
Clinical Evaluation of subcutaneous immunotherapy (SCIT) containing a mixture of mites, in depot polymerized formulation without dilutional effect. Results from a prospective multicenter study
12:00
Demystifying the fear of lack of adherence to sublingual immunotherapy (SLIT)
12:00
Descriptive study of the evolution of patients after oral immunotherapy with milk at the Hospital Universitario Fundación Alcorcón
12:00
Efficacy and safety of sublingual immunotherapy for mite in children and adolescents with AR
12:00
HDM-SLIT in general practices vs outpatient clinics
12:00
House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents
12:00
Real world data on persistence and compliance with sublingual allergen specific immunotherapy, a Dutch experience
12:00
The Effect of Japanese cedar pollen SLIT-tablets increases with years of treatment
12:00
The change in quality of life of adults with food allergy treated with oral immunotherapy
12:00
Therapeutic efficacy of a biodegradable microneedle patch loaded with peanut allergen in a peanut allergy model
12:00
When gym gains collide with an allergic reaction to whey protein
